Beta-blockers as antiarrhythmics in septic shock: a light at the end of the tunnel?
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F25%3A10488834" target="_blank" >RIV/00064165:_____/25:10488834 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/25:10488834
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=Hw3AOa3HuZ" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=Hw3AOa3HuZ</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1007/s00134-024-07713-z" target="_blank" >10.1007/s00134-024-07713-z</a>
Alternative languages
Result language
angličtina
Original language name
Beta-blockers as antiarrhythmics in septic shock: a light at the end of the tunnel?
Original language description
The attractive concept of alleviating a non-compensatory tachycardia using beta-blockers in patients with septic shock has been recently tested by two multicentric trials which either did not show a positive impact on the outcome [1] or demonstrated a possible medication associated harm (Stress-L trial). The Landi-SEP [1] randomized into each arm about 95 non-selected patients with septic shock and tachycardia, of whom one-fourth had atrial fibrillation (AF). The results of Landi-SEP do not support a stringent heart rate reduction below 95 bpm in a septic shock population with a persistent tachycardia. Similarly to the J-Land3S trial [2], the landiolol was effective in reducing heart rate and treating supraventricular arrhythmias, which are known to worsen the outcomes of the critically ill.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30221 - Critical care medicine and Emergency medicine
Result continuities
Project
<a href="/en/project/NV18-06-00417" target="_blank" >NV18-06-00417: Prospective randomized double-blind study of efficacy and safety of 1c class antiarrhythmic agent (propafenone) for supraventricular arrhythmias in septic shock</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Intensive Care Medicine
ISSN
0342-4642
e-ISSN
1432-1238
Volume of the periodical
51
Issue of the periodical within the volume
1
Country of publishing house
US - UNITED STATES
Number of pages
3
Pages from-to
232-234
UT code for WoS article
001353461500001
EID of the result in the Scopus database
2-s2.0-85208986571